BARK vs FRPT vs CHWY vs HIMS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -1. 2% for BARK, Inc. (BARK). Freshpet, Inc. (FRPT) offers the better valuation at 21. 2x trailing P/E (41. 1x forward), making it the more compelling value choice. Analysts rate BARK, Inc. (BARK) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Freshpet, Inc.

(FRPT) is the cheapest at 21. 2x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Chewy, Inc. is actually cheaper at 27. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -95. 3% for BARK, Inc. (BARK). Over 10 years, the gap is even starker: FRPT returned +517. 3% versus BARK's -96. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Chewy, Inc.

(CHWY) is the lower-risk stock at 0. 70β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 241% more volatile than CHWY relative to the S&P 500. On balance sheet safety, Freshpet, Inc. (FRPT) carries a lower debt/equity ratio of 46% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -1. 2% for BARK, Inc. (BARK). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Freshpet, Inc.

(FRPT) is the more profitable company, earning 12. 6% net margin versus -6. 8% for BARK, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FRPT leads at 8. 6% versus -7. 3% for BARK. At the gross margin level — before operating expenses — BARK leads at 62. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Chewy, Inc.

(CHWY) trades at 27. 0x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 24. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BARK: 220. 9% to $30. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Freshpet, Inc.

(FRPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91), +517. 3% 10Y return). BARK, Inc. (BARK) carries a higher beta of 1. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FRPT: +517. 3%, BARK: -96. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BARK (Consumer Cyclical) and FRPT (Consumer Defensive) and CHWY (Consumer Cyclical) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BARK is a small-cap quality compounder stock; FRPT is a small-cap quality compounder stock; CHWY is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.